244 related articles for article (PubMed ID: 32524598)
1. Progesterone and preterm birth.
Norman JE
Int J Gynaecol Obstet; 2020 Jul; 150(1):24-30. PubMed ID: 32524598
[TBL] [Abstract][Full Text] [Related]
2. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis.
Conde-Agudelo A; Romero R; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Erez O; Pacora P; Nicolaides KH
Am J Obstet Gynecol; 2018 Jul; 219(1):10-25. PubMed ID: 29630885
[TBL] [Abstract][Full Text] [Related]
3. Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials.
EPPPIC Group
Lancet; 2021 Mar; 397(10280):1183-1194. PubMed ID: 33773630
[TBL] [Abstract][Full Text] [Related]
4. Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study.
Romero R; Nicolaides KH; Conde-Agudelo A; O'Brien JM; Cetingoz E; Da Fonseca E; Creasy GW; Hassan SS
Ultrasound Obstet Gynecol; 2016 Sep; 48(3):308-17. PubMed ID: 27444208
[TBL] [Abstract][Full Text] [Related]
5. Vaginal progesterone compared with intramuscular 17-alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth in singleton gestations: a systematic review and meta-analysis.
Boelig RC; Locci M; Saccone G; Gragnano E; Berghella V
Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100658. PubMed ID: 35562009
[TBL] [Abstract][Full Text] [Related]
6. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
O'Brien JM; Lewis DF
Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
[TBL] [Abstract][Full Text] [Related]
7. Vaginal progesterone vs intramuscular 17α-hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth in singleton gestations: systematic review and meta-analysis of randomized controlled trials.
Saccone G; Khalifeh A; Elimian A; Bahrami E; Chaman-Ara K; Bahrami MA; Berghella V
Ultrasound Obstet Gynecol; 2017 Mar; 49(3):315-321. PubMed ID: 27546354
[TBL] [Abstract][Full Text] [Related]
8. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.
Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P
J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230
[TBL] [Abstract][Full Text] [Related]
9. Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.
Dodd JM; Grivell RM; OBrien CM; Dowswell T; Deussen AR
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012024. PubMed ID: 29086920
[TBL] [Abstract][Full Text] [Related]
10. Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial.
Boelig RC; Schoen CN; Frey H; Gimovsky AC; Springel E; Backley S; Berghella V
Am J Obstet Gynecol; 2022 May; 226(5):722.e1-722.e12. PubMed ID: 35189093
[TBL] [Abstract][Full Text] [Related]
11. Trial protocol OPPTIMUM-- does progesterone prophylaxis for the prevention of preterm labour improve outcome?
Norman JE; Shennan A; Bennett P; Thornton S; Robson S; Marlow N; Norrie J; Petrou S; Sebire N; Lavender T; Whyte S
BMC Pregnancy Childbirth; 2012 Aug; 12():79. PubMed ID: 22866909
[TBL] [Abstract][Full Text] [Related]
12. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data.
Romero R; Conde-Agudelo A; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Nicolaides KH
Am J Obstet Gynecol; 2018 Feb; 218(2):161-180. PubMed ID: 29157866
[TBL] [Abstract][Full Text] [Related]
13. Interventions to prevent spontaneous preterm birth in women with singleton pregnancy who are at high risk: systematic review and network meta-analysis.
Care A; Nevitt SJ; Medley N; Donegan S; Good L; Hampson L; Tudur Smith C; Alfirevic Z
BMJ; 2022 Feb; 376():e064547. PubMed ID: 35168930
[TBL] [Abstract][Full Text] [Related]
14. Pessary or Progesterone to Prevent Preterm delivery in women with short cervical length: the Quadruple P randomised controlled trial.
van Zijl MD; Koullali B; Naaktgeboren CA; Schuit E; Bekedam DJ; Moll E; Oudijk MA; van Baal WM; de Boer MA; Visser H; van Drongelen J; van de Made FW; Vollebregt KC; Muller MA; Bekker MN; Brons JTJ; Sueters M; Langenveld J; Franssen MT; Schuitemaker NW; van Beek E; Scheepers HCJ; de Boer K; Tepe EM; Huisjes AJM; Hooker AB; Verheijen ECJ; Papatsonis DN; Mol BWJ; Kazemier BM; Pajkrt E
BMC Pregnancy Childbirth; 2017 Sep; 17(1):284. PubMed ID: 28870155
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of short cervix between 20 and 24 weeks of gestation and vaginal progesterone for prolonging of gestation.
Maerdan M; Shi C; Zhang X; Fan L
J Matern Fetal Neonatal Med; 2017 Jul; 30(14):1646-1649. PubMed ID: 27600865
[TBL] [Abstract][Full Text] [Related]
16. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data.
Romero R; Conde-Agudelo A; El-Refaie W; Rode L; Brizot ML; Cetingoz E; Serra V; Da Fonseca E; Abdelhafez MS; Tabor A; Perales A; Hassan SS; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Mar; 49(3):303-314. PubMed ID: 28067007
[TBL] [Abstract][Full Text] [Related]
17. A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix.
Romero R; Yeo L; Miranda J; Hassan SS; Conde-Agudelo A; Chaiworapongsa T
J Perinat Med; 2013 Jan; 41(1):27-44. PubMed ID: 23314512
[TBL] [Abstract][Full Text] [Related]
18. Cervical cerclage for singleton pregnant patients on vaginal progesterone with progressive cervical shortening.
Enakpene CA; DiGiovanni L; Jones TN; Marshalla M; Mastrogiannis D; Della Torre M
Am J Obstet Gynecol; 2018 Oct; 219(4):397.e1-397.e10. PubMed ID: 30017683
[TBL] [Abstract][Full Text] [Related]
19. Progestogens for the prevention of preterm birth and risk of developing gestational diabetes mellitus: a meta-analysis.
Pergialiotis V; Bellos I; Hatziagelaki E; Antsaklis A; Loutradis D; Daskalakis G
Am J Obstet Gynecol; 2019 Nov; 221(5):429-436.e5. PubMed ID: 31132340
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of randomized controlled trials comparing 17α-hydroxyprogesterone caproate and vaginal progesterone for the prevention of recurrent spontaneous preterm delivery.
Oler E; Eke AC; Hesson A
Int J Gynaecol Obstet; 2017 Jul; 138(1):12-16. PubMed ID: 28369874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
